Biopharma Plasma LLC Report issue

For profit Phase 3
Founded: Kiv Ukraine (1896)

Organization Overview

First Clinical Trial
2020
NCT04500067
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Biopharma Plasma LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2